WallStSmart
VERO

Venus Concept Inc

NASDAQ: VERO · HEALTHCARE · MEDICAL DEVICES

$0.31
+0.00% today

Updated 2026-04-30

Market cap
$578190.00
P/E ratio
P/S ratio
0.01x
EPS (TTM)
$-45.26
Dividend yield
52W range
$0 – $8
Volume
0.0M

Venus Concept Inc (VERO) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2015201620172018201920202021202220232024
Revenue$17.23M$15.60M$21.30M$21.96M$110.41M$78.01M$105.62M$99.50M$76.35M$64.83M
Revenue growth (YoY)-9.5%+36.5%+3.1%+402.9%-29.3%+35.4%-5.8%-23.3%-15.1%
Cost of revenue$12.51M$10.43M$12.15M$12.45M$33.75M$26.62M$31.53M$33.53M$24.19M$20.53M
Gross profit$4.72M$5.17M$9.15M$9.51M$76.65M$51.39M$74.09M$65.97M$52.17M$44.31M
Gross margin27.4%33.1%42.9%43.3%69.4%65.9%70.2%66.3%68.3%68.3%
R&D$7.40M$7.47M$7.13M$8.37M$8.03M$7.75M$8.26M$10.95M$8.20M$6.69M
SG&A$3.26M$4.14M$4.90M$8.83M$47.50M$57.88M$45.94M$49.62M$41.05M$36.47M
Operating income$-20.52M$-18.93M$-17.28M$-25.91M$-20.29M$-40.45M$-17.54M$-34.88M$-28.31M$-27.18M
Operating margin-119.1%-121.4%-81.1%-118.0%-18.4%-51.8%-16.6%-35.1%-37.1%-41.9%
EBITDA$-19.22M$-18.71M$-15.19M$-25.91M$-18.25M$-35.64M$-12.69M$-35.28M$-26.11M$-36.04M
EBITDA margin-111.5%-119.9%-71.3%-118.0%-16.5%-45.7%-12.0%-35.5%-34.2%-55.6%
EBIT$-20.08M$-19.36M$-15.76M$-27.25M$-20.29M$-40.45M$-17.54M$-39.74M$-30.23M$-39.93M
Interest expense$2.89M$2.48M$2.03M$2.22M$7.55M$8.34M$4.96M$4.56M$6.89M$7.66M
Income tax$3.34M$2.05M$56000.00$47000.00$1.86M$1.18M$-707000.00$-722000.00$-71000.00$-611000.00
Effective tax rate-17.0%-10.4%-0.3%-0.2%-4.6%-1.4%3.1%1.6%0.2%1.3%
Net income$-22.97M$-21.85M$-17.84M$-28.73M$-42.30M$-82.82M$-22.14M$-43.70M$-37.25M$-47.00M
Net income growth (YoY)+4.9%+18.3%-61.0%-47.2%-95.8%+73.3%-97.4%+14.8%-26.2%
Profit margin-133.3%-140.0%-83.8%-130.8%-38.3%-106.2%-21.0%-43.9%-48.8%-72.5%